» Articles » PMID: 8536550

Guidelines for General Practitioners Administering Thrombolytics

Overview
Journal Drugs
Specialty Pharmacology
Date 1995 Oct 1
PMID 8536550
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Acute myocardial infarction (AMI) recognises no boundaries, and the patient's greatest need occurs at the interface between primary care and hospital system. Ideally, the general practitioner, if summoned, should be able to provide resuscitation, analgesia with opiates, and thrombolytic therapy. Thrombolytics should certainly be given to eligible patients by the general practitioner if an hour could be saved by so doing. Optimising the risk-benefit ratio for thrombolytic therapy given in the community is a challenge to clinical judgement. Experience with this potent treatment is best obtained under a degree of supervision, which could take the form of an audit of the prehospital management of suspected AMI. With prehospital administration of thrombolytic therapy at the first opportunity, the chances of saving a life are better than 1 in 10, while the excess risk of a disabling stroke is about 1 in 1000.

Citing Articles

Cost implications of prehospital emergency drug administration. The case of prehospital thrombolytics.

Barton S, Walley T Pharmacoeconomics. 1996; 10(5):441-52.

PMID: 10163626 DOI: 10.2165/00019053-199610050-00001.


Audit of prehospital thrombolysis by general practitioners in peripheral practices in Grampian.

Rawles J, Sinclair C, Jennings K, Ritchie L, Waugh N Heart. 1999; 80(3):231-4.

PMID: 9875080 PMC: 1761099. DOI: 10.1136/hrt.80.3.231.


Call to needle times after acute myocardial infarction in urban and rural areas in northeast Scotland: prospective observational study.

Rawles J, Sinclair C, Jennings K, Ritchie L, Waugh N BMJ. 1998; 317(7158):576-8.

PMID: 9721115 PMC: 28652. DOI: 10.1136/bmj.317.7158.576.

References
1.
Weaver W, Cerqueira M, Hallstrom A, Litwin P, Martin J, Kudenchuk P . Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993; 270(10):1211-6. View

2.
. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med. 1993; 329(6):383-9. DOI: 10.1056/NEJM199308053290602. View

3.
Gang E, Lew A, Hong M, Wang F, Siebert C, Peter T . Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1989; 321(11):712-6. DOI: 10.1056/NEJM198909143211104. View

4.
Mathewson Z, McCloskey B, Evans A, Russell C, Wilson C . Mobile coronary care and community mortality from myocardial infarction. Lancet. 1985; 1(8426):441-4. DOI: 10.1016/s0140-6736(85)91156-0. View

5.
. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 1993; 329(22):1615-22. DOI: 10.1056/NEJM199311253292204. View